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Abstract  
Numerous studies have stated that humans need to utilise full sun radiation, at certain times of the 
day, to assist the body in synthesising the required levels of vitamin D3. The time needed to be 
spent in the full sun depends on a number of factors, for example, age, skin type, latitude, solar 
zenith angle. Current Australian guidelines suggest exposure to approximately 1/6 to 1/3 of a 
minimum erythemal dose (MED), depending on age, would be appropriate to provide adequate 
vitamin D3 levels. The aim of the study was to determine the exposure times to diffuse solar UV to 
receive exposures of 1/6 and 1/3 MED for a changing solar zenith angle in order to assess the 
possible role that diffuse UV (scattered radiation) may play in vitamin D3 effective UV exposures 
(UVD3). Diffuse and global erythemal UV measurements were conducted at five minute intervals 
over a twelve month period for a solar zenith angle range of 4o to 80o at a latitude of 27.6oS. For a 
diffuse UV exposure of 1/3 MED, solar zenith angles smaller than approximately 50o can be utilised 
for exposure times of less than 10 minutes. Spectral measurements showed that, for a solar zenith 
angle of 40o, the UVA (315-400 nm) in the diffuse component of the solar UV is reduced by 
approximately 62% compared to the UVA in the global UV, whereas UVD3 wavelengths are only 
reduced by approximately 43%. At certain latitudes, diffuse UV under shade may play an important 
role in providing the human body with adequate levels of UVD3 (290-315 nm) radiation without 
experiencing the high levels of UVA observed in full sun.  
 
 
1 Introduction 
The health effects of solar UV radiation vary significantly, from initiating the synthesis of vitamin 
D3 to the severe degradation of the human body. Excessive solar UV radiation exposure led to the 
premature deaths of approximately 60 000 people in the year 2000 (Lucas et al, 2006). It is well 
known that exposure to small amounts of UV radiation are beneficial for the human body and 
important in the production of vitamin D3, whereas excessive exposure to sunlight is known to 
cause skin cancer, immune suppression, DNA damage, erythema and sun-related eye disorders 
(Baron et al., 2003; Glerup et al., 2000; Terenetskaya, 2000; Sliney, 2004; Setlow et al., 1993). 
Approximately 90-95% of our vitamin D3 requirement comes from exposure to the sun (Holick, 
2004; Holick, 1998). The synthesis of pre-vitamin D3 is initiated through exposure of human skin to 
terrestrial UV radiation from 290 to 315 nm. The longer wavelength UV radiation (greater than 315 
nm) plays no part in the synthesis of pre-vitamin D3 in humans. Although, over exposure to UV 
wavelengths is known to cause damage, vitamin D3 synthesis occurs at doses far below those 
needed for erythema to arise (Webb, 1993). Small amounts of vitamin D3 can also be obtained from 
some foods, for example oily fish and eggs or by fortifying foods with vitamin D3. It has been 
shown that the vitamin D3 from these sources cannot provide sufficient vitamin D3 for the elderly 
(Mosekilde, 2005). Vitamin D3 can also be obtained through vitamin tablets; however the simplest 
way to obtain vitamin D3 is from moderate exposure to sunlight (Holick, 2004). Furthermore, this is 
also the cheapest way without the cost burden of vitamin tablets. 
 
Current Australian guidelines suggest exposure to approximately 1/6 to 1/3 of a MED (minimum 
erythemal dose), depending on age, would be appropriate to provide adequate vitamin D3 levels 
(Samanek et al., 2006; CDHAA, 2004). Older people require more frequent exposures as vitamin 
D3 production rates are about 1/5 as high for the elderly as for the young (Holick et al., 1989). Also, 
people with highly pigmented skin would require exposures 3-4 times greater than those necessary 
for fair skinned people (Pathak et al., 1999). Recent research suggests that the optimal serum 
vitamin D3 level for bone health and protection against other diseases is between 800 and 2000 IU 
per day (Aloia and Li-Ng, 2007; Lappe et al., 2007; Vieth et al., 2007; Dawson-Hughes et al., 
2005); with 1000 IU equivalent to exposing 15% of the human body to approximately 1/3 MED 
(PS, 2006). A position statement was recently approved by the Working Group of the Australian 
and New Zealand Bone and Mineral Society, Endocrine Society, Osteoporosis Australia, Australian 
College of Dermatologists and the Cancer Council Australia recommending five minutes solar UV 
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exposure either side of the peak UV periods on most days of the week in summer and 
approximately 2-3 hours solar UV exposure over a week in winter (PS, 2006). This position 
statement is still behind emerging scientific findings (e.g. Giovannucci et al., 2006; Grant et al., 
2007; Gorham et al., 2007; Garland et al., 2007). Nevertheless, it is still the most up to date 
statement that has been distributed to the public. The position statement is also a generalized report 
as sun exposure varies significantly with latitude and atmospheric conditions. 
 
Solar UV radiation is incident on the earth’s surface in two distinct components, direct and diffuse. 
The direct component is straight forward to minimise by simply blocking its path, whereas the 
diffuse component is incident from all directions and is difficult to minimise. Atmospheric 
scattering which is influenced by factors such as solar zenith angle (SZA), clouds and atmospheric 
constituents plays a major role in determining the proportions of UVB (280-315 nm) and UVA 
(315-400 nm) in diffuse UV, with greater scattering occurring at the shorter UVB wavelengths than 
at the longer wavelength UVA. Turnbull et al. (2005) found that UVA was reduced by as much as 
65% when utilising a shade umbrella, whereas UVB exposures were only reduced by approximately 
48%. Therefore, at certain SZA, the diffuse UV may provide adequate levels of the effective 
wavelengths needed for vitamin D3 production (UVD3), without producing erythema. In 
comparison, mutagenic and carcinogenic effects on human skin have been shown to be caused by 
exposure to UVA radiation (Agar et al., 2004; Moan et al., 1999; Garland et al., 2003). Therefore, 
reducing personal exposures to UVA radiation while still receiving sufficient amounts of the UVD3 
wavelengths required to produce recommended vitamin D3 levels is essential. 
The importance of this research is that it provides a basis for public health campaigns aimed at 
reducing the incidence of hypovitaminosis D and its attendant disorders, as well as reducing over 
exposure to harmful solar UV radiation. In the light of the considerable body of evidence regarding 
the harm done by excessive UV exposure and the public awareness of skin cancer, any new public 
health program would need to avoid confusing the public with seemingly opposing messages. 
Utilizing diffuse solar UV radiation to obtain beneficial amounts of UV, while at the same time 
minimizing personal overexposure to UVA radiation may prove to be absolutely necessary for an 
improvement in public health. Studies have shown that shade structures are important as a UV 
minimisation strategy; however, shade settings may also play an important role in providing 
exposures to the human body with adequate levels of UV radiation for vitamin D3 production 
without experiencing the higher levels of UVA experienced in full sun. The lengths of exposure to 
solar UV at noon in major Australian cities to produce exposures of 1/3 and 1/6 MED has 
previously been reported (Samanek et al., 2006). Shade as a protective device has been discussed 
numerous times before (e.g. Turnbull and Parisi, 2006) and it is not the aim of this paper. This 
current paper is about the exposures that humans may receive when utilising solar UV for vitamin 
D3 synthesis and the possible methods to optimise this radiation. The author’s are unaware of any 
similar research or attempts to show how solar UV exposures can be optimised so humans can 
receive adequate vitamin D3 levels as well as reducing their total UV exposure. 
 
 
2 Materials and Methods 
 
2.1 Integrated Automated Cloud and Spectral UV Measurement System  
An integrated automated cloud and spectral UV measurement system was employed at a Southern 
Hemisphere site at Toowoomba, Australia (27.6 °S, 151.9 °E, 693 m above sea level) for 
automatically measuring every five minutes both the cloud fraction and the UV spectrum. The 
system was located on the roof of a building with relatively unobstructed views and the surrounding 
topography does not provide any significant obstruction to the field of view of the instruments.  
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The cloud detection system is a Total Sky Imager (TSI) (model TSI-440, Yankee Environmental 
Systems, MA, USA) with approximately 160o field of view of the sky. The TSI consists of a CCD 
camera suspended over a hemispherical reflective dome that points upwards on a horizontal plane. 
For each image, digital analysis provides the fraction of cloud cover as a number between 0 and 1 
where 1 represents total cloud cover. The uncertainty in the determination of the amount of cloud 
has been reported as ±10% at least 95% of the time (Sabburg and Long, 2004). 
 
The spectral UV measurement system is located within three metres of the cloud detection system 
and is housed in an environmentally sealed box with a fibre optic connecting the diffuser to the 
input slit of the monochromator through a hole with a seal around the fibre to protect the equipment 
inside the box from the environment. The system is based on a double monochromator system 
model (DTM300, Bentham Instruments, Reading, UK) with the gratings having 2400 grooves/mm. 
The input and output slit widths on the monochromator of 0.37 mm have been selected to provide a 
bandwidth of 0.5 nm. The spectral UV data was recorded from 280 to 400 nm in 0.5 nm increments. 
The input optics are provided by a diffuser (model D6) with the manufacturer determined error 
associated with the cosine response as less than ±0.8% for a SZA up to 70o and ±3.3% for an SZA 
of 80o. The system is scheduled to scan every five minutes from 05:00 EST (Eastern Standard 
Time) to 17:00 EST and the start of the initialisation of a spectral scan is one minute before the TSI 
obtains an image of the sky. This allows the spectral scan to start at approximately the same time 
that the TSI takes the sky image. Wavelength and irradiance calibration of the spectral UV system 
was undertaken by employing the 365 nm mercury spectral line and a 150 Watt quartz halogen 
lamp with calibration traceable to the National Physical Laboratory, UK standard. 
 
2.2 Diffuse and Global Erythemal UV  
Two erythemal UV meters (UV-Biometer Model 501, Solar Light Co., Philadelphia, PA. USA) 
were employed to monitor the diffuse and global erythemal UV (UVery). The diffuse UVery meter is 
a global UVery meter that has been specifically set up to measure the diffuse erythemal radiation. It 
utilizes a shadow band, which is aligned east-west, to block the sun during the day. The shadow 
band is 0.076 m wide and the distance from the shadow band to the top of the diffuse UVery meter 
varies from 0.25 m to 0.27 m as it is moved with the seasons. The shadow band blocks out part of 
the sky view and the amount blocked has been measured at approximately 10%. A correction has 
been applied to all of the data to account for this. The diffuse and global UVery meters were set up to 
record data every five minutes. The meters are temperature stabilized to 25oC and calibrated twice a 
year during clear sky conditions against the scanning spectroradiometer. The daily atmospheric 
column of ozone as obtained from the TOMS (Total Ozone Mapping Spectrometer) ranged from 
243.5 to 337.0 DU and the SZA ranged from 4o to 80o over the twelve month measurement period 
from January to December 2003. 
 
 
3 Results 
 
3.1 Diffuse and Global Erythemal UV 
An example of diffuse and global UV spectra is shown in Figure 1a for a cloud free period on 17 
August 2005 at 11.55 EST for an SZA of 40o. This illustrates the variation in the relative 
proportions of the different wavelengths when comparing diffuse UV to global UV. For Figure 1a, 
the diffuse spectral irradiance summed over the UVA waveband was 16.8 W/m2 compared to 44.5 
W/m2 for the global UVA. Similarly, the diffuse UVB was 0.63 W/m2 compared to 1.12 W/m2 for 
global UVB. For this specific date and time, the UVA was reduced by approximately 62% 
compared to the global UVA, whereas the diffuse UVB was only reduced by approximately 44%. 
The ratio of the diffuse to global UV plotted on the right hand axis of Figure 1b gives an indication 
of the change in ratio when comparing global and diffuse UV wavelengths.  
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Figure 1b provides the global and diffuse solar UV spectra (from Figure 1a) weighted with the pre-
vitamin D (CIE, 2006) action spectrum. Pre-vitamin D3 exposure was reduced by 43% whereas 
UVA exposure was reduced by 64%. These spectral measurements were obtained using the spectral 
measurement system described earlier. 
 
3.2 Exposure times for 1/3 MED 
The times required for an exposure of 1/3 MED on a horizontal plane for SZA greater than 4o for 
the atmospheric and cloud conditions during 2003 are shown in Figure 3a for diffuse and Figure 3b 
for global UVery. Over 25,000 data points are provided in each figure for diffuse and global UVery 
for all SZA, sky and atmospheric conditions encountered over this period. The average times for an 
exposure equivalent to 1/3 MED for vitamin D3 and erythema are shown in Table 1 for diffuse and 
global UV. For a SZA of 5o, the average time needed to receive an exposure of 1/3 MED due to 
erythemal UV was 4.4 and 6.8 minutes for global and diffuse respectively. Whereas, the average 
time needed to receive an equivalent exposure of 1/3 MED for vitamin D3 production was 2.2 and 
3.2 minutes for global and diffuse respectively. These times are based on exposing 15% of the 
human body to UV radiation. Increasing the exposed body surface will subsequently decrease the 
time needed for vitamin D3 production (e.g. exposing three times more body surface will reduce the 
exposure times presented in this research by a factor of three). However, the time for 1/3 MED of 
erythemal effective UV will remain the same. 
 
As shown in Figure 3a and b, this data has been broken down into separate cloud levels of 0 to 80% 
and 85 to 100%, respectively. This was undertaken to illustrate that 0 to 80% of cloud cover has a 
lesser effect on the diffuse UV compared to 85 to 100% of cloud.  
 
The times required for an exposure of 1/3 MED due to the diffuse and global UVery on a horizontal 
plane expressed as a percentage of occurrence for 2003 are shown in Figure 4. For diffuse UVery, 
the maximum incidence for 1/3 MED was in the range of 5 to 10 minutes with an occurrence of 
34.9%, followed by 29.5% for 10 to 15 minutes, and 17.8% for 15 to 20 minutes. For global UVery, 
the maximum incidence of the times for 1/3 MED was in the range of 5 to 10 minutes with an 
occurrence of 32.9%, followed by 26.7% for less than or equal to 5 minutes, and 17.9% for 10 to 15 
minutes.  
 
 
4 Discussion 
Studies on the levels of UV observed in the shade of different shade environments have shown that 
the relative proportions of UVA and UVB in the shade are significantly different to those in full sun 
(Turnbull et al., 2005; Turnbull and Parisi, 2003; Turnbull et al., 2003; Parisi et al., 2001). The 
relative proportions of the UVA in shade to those in full sun are decreased compared to the relative 
proportions of the UVB in shade to those in full sun. At certain latitudes and SZA, unprotected 
exposure for short periods to the UV under shade structures may be the best course of action as it 
will contribute more toward vitamin D3 production than toward erythema compared to exposing the 
body to full sun UV due to the reduced relative component of the UVA in the shade.  
 
The average time for an exposure of 1/3 MED due to diffuse UVery was 6.8 min for a SZA of 5o. 
Whereas, the average time needed to receive an equivalent exposure of 1/3 MED for vitamin D3 
production was only 3.2 minutes. These times are longer for larger SZA and for overcast conditions. 
For an exposure of 1/3 MED, SZA smaller than approximately 50o can be utilised for exposure 
times of less than 10 minutes. For SZA between 4o to 50o, 94% of the data shows that an exposure 
of 1/3 MED requires less than 20 minutes of exposure to diffuse UV. Although the measurements 
are at one latitude, the data was collected for the SZA range of 4o to 80o. This will allow the results 
to be applicable at latitudes that experience these SZA. 
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The values provided in this paper are for pale skin and for a sky view that is not blocked, apart from 
the blocking of the solar disc. However, research is currently being conducted beneath various 
shade environments and initial results show that shade environments of at least 50% sky view 
exhibit excellent correlation with the values shown in Figure 2a. For example, at approximately 18o 
SZA the average time for 1/3 MED from diffuse UVery on a horizontal plane is approximately 7.5 
minutes. Initial results for the same SZA show that the times for 1/3 MED in the shade of a shade 
umbrella and on the southern side of a building were approximately 7 minutes and 9 minutes 
respectively. For larger structures the amount of sky view will be reduced due to the structural 
components of the shade structure, causing the exposure times required for the respective exposures 
due to the diffuse UVery to be slightly longer. Nevertheless, the findings in this paper may have 
significant ramifications for future public health policy regarding sun exposure, which is currently 
being debated in many countries (Diffey, 2006; Gillie, 2006). Also, the findings of this research 
may prove useful to those that work from 9 am to 5 pm, where solar UV exposure at noon or during 
a lunch break may be the only option for the necessary UV exposures to initiate the synthesis of 
vitamin D3. Therefore, advice to stay out of the sun in the middle of the day, which is best for 
vitamin D3 synthesis in the skin, can be adjusted to advocate the possible use of appropriate shade 
environments. However, in the shade there is the potential danger due to the filtering of the infrared 
waveband, which may cause prolonged exposures. 
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Tables 
 
Table 1. Average times for an exposure equivalent to 1/3 MED for vitamin D3 and erythemal 
effective UV radiation. 
  Global UVD3 Diffuse UVD3 Global UVery Diffuse UVery 
SZA (min) (min) (min) (min) 
5o 2.2 (0.8) 3.2 (0.5) 4.4 (2.5) 6.8 (2.8) 
15o 2.5 (3.4) 3.9 (3.1) 5.1 (5.9) 7.7 (5.2) 
25o 2.8 (1.8) 4.5 (2.6) 6.0 (4.5) 8.7 (4.0) 
35o 3.5 (2.0) 5.2 (2.5) 7.1 (4.2) 10.2 (4.3) 
45o 5.7 (3.8) 7.1 (3.1) 10.8 (6.6) 13.7 (5.4) 
55o 10.1 (5.9) 13.2 (7.7) 19.9 (16.5) 24.2 (16.3) 
65o 27.5 (19.0) 27.2 (17.2) 42.0 (30.8) 43.6 (25.1) 
75o 103.3 (63.5) 97.7 (47.7) 110.3 (56.3) 111.6 (49.3) 
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Figure Legends 
 
Figure 1 – Diffuse (light line) and global (heavy line) spectral UV irradiances taken on 17 August 
2005 at approximately 11:00 EST and the spectral ratio of diffuse to global UV (a); and 
global and diffuse spectral irradiances from (a) weighted with the pre-vitamin D3 action 
spectrum (CIE, 2006). 
 
Figure 2 – The times required for an exposure of 1/3 MED due to diffuse UVery (a) and global UVery 
(b) as a function of SZA for all sky conditions during 2003. 
 
Figure 3 – Times for exposure to 1/3 MED of diffuse UV for cloud cover of 0 to 80% (a) and 85 to 
100% (b).  
 
Figure 4 – The percentage of instances when the time required for an exposure of 1/3 MED due to 
diffuse (grey bar) and global (black bar) UVery falls within a certain time range 
(provided in units of minutes).  
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Figure 1. Diffuse (light line) and global (heavy line) spectral UV irradiances taken on 17 August 
2005 at approximately 11:00 EST and the spectral ratio of diffuse to global UV (a); and global and 
diffuse spectral irradiances from (a) weighted with the pre-vitamin D3 action spectrum (CIE, 2006).  
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Figure 2. The times required for an exposure of 1/3 MED due to diffuse UVery (a) and global UVery 
(b) as a function of SZA for all sky conditions during 2003. 
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Figure 3. Times for exposure to 1/3 MED of diffuse UV for cloud cover of 0 to 80% (a) and 85 to 
100% (b). 
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Figure 4. The percentage of instances when the time required for an exposure of 1/3 MED due to 
diffuse (grey bar) and global (black bar) UVery falls within a certain time range (provided in units of 
minutes).   
 14
